Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Musiani

Showing results (141-150 of 151) with videos related to

Pageof 16
Sort By:
International Journal of Immunopathology and Pharmacology|May 13, 2005
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic miceM Lo Iacono, F Cavallo, E Quaglino, et al.
Human Gene Therapy|February 24, 1998
The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cellsP Nanni, C De Giovanni, G Nicoletti, et al.
Gene Therapy|March 15, 2002
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gammaC De Giovanni, G Nicoletti, L Landuzzi, et al.
The EMBO Journal|October 2, 1998
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liverD Maione, E Di Carlo, W Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytesM Giovarelli, P Cappello, G Forni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c miceS Rovero, A Amici, E Di Carlo, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
Pageof 16

Showing results (141-150 of 151) with videos related to

Sort By:
Pageof 16
International Journal of Immunopathology and Pharmacology|May 13, 2005
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic miceM Lo Iacono, F Cavallo, E Quaglino, et al.
Human Gene Therapy|February 24, 1998
The immune response elicited by mammary adenocarcinoma cells transduced with interferon-gamma and cytosine deaminase genes cures lung metastases by parental cellsP Nanni, C De Giovanni, G Nicoletti, et al.
Gene Therapy|March 15, 2002
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gammaC De Giovanni, G Nicoletti, L Landuzzi, et al.
The EMBO Journal|October 2, 1998
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liverD Maione, E Di Carlo, W Li, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytesM Giovarelli, P Cappello, G Forni, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 25, 2000
DNA vaccination against rat her-2/Neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c miceS Rovero, A Amici, E Di Carlo, et al.
The Journal of Experimental Medicine|November 7, 2001
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic miceP Nanni, G Nicoletti, C De Giovanni, et al.
International Journal of Cancer|June 22, 2000
p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinomaP Nanni, S M Pupa, G Nicoletti, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 1999
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactionsM Giovarelli, P Musiani, G Garotta, et al.
The Journal of Experimental Medicine|August 4, 1998
Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic miceK Boggio, G Nicoletti, E Di Carlo, et al.
Pageof 16